Finance

Lists
Why is SUS down 8.66%?
Dive Deeper
SUS:STO
Surgical Science Sweden AB
SEK 56.95
-8.66%
(-5.40) 1D
Nov 12, 1:11:55 PM GMT+1  ·   SEK
All symbols
SymbolPriceChange% Change
Generating top insights for SUS...
Open
SEK 55.00
High
SEK 57.95
Low
SEK 50.00
Mkt. cap
2.92B
Avg. vol.
144.36K
Volume
688.50K
P/E ratio
31.34
52-wk high
SEK 85.00
52-wk low
SEK 23.70
EPS
SEK 1.83
Shares outstanding
51.03M
No. of employees
319
Open
SEK 55.00
High
SEK 57.95
Low
SEK 50.00
Mkt. cap
2.92B
Avg. vol.
144.36K
Volume
688.50K
P/E ratio
31.34
52-wk high
SEK 85.00
52-wk low
SEK 23.70
EPS
SEK 1.83
Shares outstanding
51.03M
No. of employees
319
News stories
From web sources and news partners
About Surgical Science Sweden AB
CEOGisli Hennermark
Employees319
Founded1997
Headquarters-
SectorHealth Care
IndustryMedical device
Websitesurgicalscience.com
Previous reportsAll values in SEK
Loading Previous Earnings...
Revenue
Net income
All values in SEK
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
263.64M
268.85M
235.48M
254.52M
Cost of goods sold
93.21M
90.60M
80.51M
78.23M
Cost of revenue
93.21M
90.60M
80.51M
78.23M
Research and development expenses
55.03M
59.75M
57.97M
59.18M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
75.45M
71.50M
63.58M
73.43M
Operating expense
134.48M
133.51M
128.30M
134.60M
Total operating expenses
227.69M
224.11M
208.81M
212.83M
Operating income
35.95M
44.74M
26.67M
41.68M
Other non operating income
499.00K
-134.00K
-2.74M
-4.11M
EBT including unusual items
30.15M
42.49M
21.63M
31.78M
EBT excluding unusual items
31.65M
38.39M
25.43M
31.78M
Income tax expense
9.75M
9.24M
3.00M
10.92M
Effective tax rate
32.33%
21.74%
13.89%
34.38%
Other operating expenses
4.00M
2.26M
6.75M
1.99M
Net income
20.40M
33.26M
18.63M
20.85M
Net profit margin
7.74%
12.37%
7.91%
8.19%
Earnings per share
0.40
0.69
0.37
0.48
Interest and investment income
2.60M
5.22M
2.30M
3.20M
Interest expense
-200.00K
-1.65M
-800.00K
-
Net interest expenses
2.40M
3.57M
1.50M
3.20M
Depreciation and amortization charges
-
-
-
-
EBITDA
48.52M
62.39M
38.83M
55.49M
Gain or loss from assets sale
-
-
-
-
Upcoming events
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps